Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.
Amazon is leading the trio of tech heavyweights in commitments, putting up $50 billion, followed by $30 billion each from Nvidia and SoftBank, said OpenAI co-founder and CEO Sam Altman on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results